These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 34688152)
1. Senescence marker protein 30 (SMP30) protects against high glucose-induced apoptosis, oxidative stress and inflammatory response in retinal ganglion cells by enhancing Nrf2 activation via regulation of Akt/GSK-3β pathway. Zhang L; Zhu T; He F; Li X Int Immunopharmacol; 2021 Dec; 101(Pt B):108238. PubMed ID: 34688152 [TBL] [Abstract][Full Text] [Related]
2. Sulfiredoxin-1 protects retinal ganglion cells from high glucose-induced oxidative stress and inflammatory injury by potentiating Nrf2 signaling via the Akt/GSK-3β pathway. Zhu F; Shao J; Tian Y; Xu Z Int Immunopharmacol; 2021 Dec; 101(Pt B):108221. PubMed ID: 34653733 [TBL] [Abstract][Full Text] [Related]
3. Loss of serine/threonine protein kinase 25 in retinal ganglion cells ameliorates high glucose-elicited damage through regulation of the AKT-GSK-3β/Nrf2 pathway. Zhou Z; Li H; Bai S; Xu Z; Jiao Y Biochem Biophys Res Commun; 2022 Apr; 600():87-93. PubMed ID: 35217361 [TBL] [Abstract][Full Text] [Related]
4. Loss of pleckstrin homology domain and leucine-rich repeat protein phosphatase 2 has protective effects on high glucose-injured retinal ganglion cells via the effect on the Akt-GSK-3β-Nrf2 pathway. Liu X; Liu Y; Chen L; Zhang Z; Cui L; Wei T Inflamm Res; 2023 Mar; 72(3):373-385. PubMed ID: 36562794 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of PHLPP1 ameliorates high glucose-evoked injury in retinal ganglion cells by attenuating apoptosis and oxidative stress through enhancement of Nrf2 activation. Zhang X; Lu Y; He N; Wang F Exp Cell Res; 2020 Dec; 397(2):112344. PubMed ID: 33164862 [TBL] [Abstract][Full Text] [Related]
6. Perilipin 5 ameliorates high-glucose-induced podocyte injury via Akt/GSK-3β/Nrf2-mediated suppression of apoptosis, oxidative stress, and inflammation. Feng J; Xie L; Yu X; Liu C; Dong H; Lu W; Kong R Biochem Biophys Res Commun; 2021 Mar; 544():22-30. PubMed ID: 33516878 [TBL] [Abstract][Full Text] [Related]
7. PLK2 protects retinal ganglion cells from oxidative stress by potentiating Nrf2 signaling via GSK-3β. Fan Y; Wang J; He N; Feng H J Biochem Mol Toxicol; 2021 Aug; 35(8):e22815. PubMed ID: 34047419 [TBL] [Abstract][Full Text] [Related]
8. Decreasing REDD1 expression protects against high glucose-induced apoptosis, oxidative stress and inflammatory injury in podocytes through regulation of the AKT/GSK-3β/Nrf2 pathway. Wang X; Yang J; Wang W; Li Y; Yang Y Immunopharmacol Immunotoxicol; 2023 Oct; 45(5):527-538. PubMed ID: 36883011 [TBL] [Abstract][Full Text] [Related]
9. TRIM32 Inhibition Attenuates Apoptosis, Oxidative Stress, and Inflammatory Injury in Podocytes Induced by High Glucose by Modulating the Akt/GSK-3β/Nrf2 Pathway. Chen Z; Tian L; Wang L; Ma X; Lei F; Chen X; Fu R Inflammation; 2022 Jun; 45(3):992-1006. PubMed ID: 34783942 [TBL] [Abstract][Full Text] [Related]
10. Senescence marker protein 30 confers neuroprotection in oxygen-glucose deprivation/reoxygenation-injured neurons through modulation of Keap1/Nrf2 signaling: Role of SMP30 in OGD/R-induced neuronal injury. Liu W; Zhao H; Su Y; Wang K; Li J; Xue S; Sun X; Qiu Z Hum Exp Toxicol; 2021 Mar; 40(3):472-482. PubMed ID: 32909858 [TBL] [Abstract][Full Text] [Related]
11. Perilipin 5 protects against oxygen-glucose deprivation/reoxygenation-elicited neuronal damage by inhibiting oxidative stress and inflammatory injury via the Akt-GSK-3β-Nrf2 pathway. Huo K; Ma KG; Guo QY; Duan P; Xu J Int Immunopharmacol; 2022 Jul; 108():108718. PubMed ID: 35367744 [TBL] [Abstract][Full Text] [Related]
12. The Nrf2 activator MIND4-17 protects retinal ganglion cells from high glucose-induced oxidative injury. Chen N; Li Y; Huang N; Yao J; Luo WF; Jiang Q J Cell Physiol; 2020 Oct; 235(10):7204-7213. PubMed ID: 32020639 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of heme oxygenase-1 by Brahma-related gene 1 through Nrf2 signaling confers protective effect against high glucose-induced oxidative damage of retinal ganglion cells. Sun W; Yu J; Kang Q Eur J Pharmacol; 2020 May; 875():173038. PubMed ID: 32105681 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of TNFAIP1 ameliorates the oxidative stress and inflammatory injury in myocardial ischemia/reperfusion injury through modulation of Akt/GSK-3β/Nrf2 pathway. Wen L; Yang QH; Ma XL; Li T; Xiao S; Sun CF Int Immunopharmacol; 2021 Oct; 99():107993. PubMed ID: 34330059 [TBL] [Abstract][Full Text] [Related]
15. Sulfiredoxin-1 alleviates high glucose-induced podocyte injury though promoting Nrf2/ARE signaling via inactivation of GSK-3β. Shen Y; Chen S; Zhao Y Biochem Biophys Res Commun; 2019 Sep; 516(4):1137-1144. PubMed ID: 31284950 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of BRD7 protects podocytes against high glucose-induced apoptosis by enhancing Nrf2 in a GSK-3β-dependent manner. Yu X; Jiang N; Li J; Li X; He S Tissue Cell; 2022 Jun; 76():101813. PubMed ID: 35550209 [TBL] [Abstract][Full Text] [Related]
17. TDAG51-Deficiency Podocytes are Protected from High-Glucose-Induced Damage Through Nrf2 Activation via the AKT-GSK-3β Pathway. Liu C; Li Y; Wang X Inflammation; 2022 Aug; 45(4):1520-1533. PubMed ID: 35175494 [TBL] [Abstract][Full Text] [Related]
18. Glutaredoxin 1 protects neurons from oxygen-glucose deprivation/reoxygenation (OGD/R)-induced apoptosis and oxidative stress via the modulation of GSK-3β/Nrf2 signaling. Qiu Z; Li X; Duan C; Li R; Han L J Bioenerg Biomembr; 2021 Aug; 53(4):369-379. PubMed ID: 33956252 [TBL] [Abstract][Full Text] [Related]
19. Glutaredoxin 2 protects cardiomyocytes from hypoxia/reoxygenation-induced injury by suppressing apoptosis, oxidative stress, and inflammation via enhancing Nrf2 signaling. Li C; Xin H; Shi Y; Mu J Int Immunopharmacol; 2021 May; 94():107428. PubMed ID: 33581580 [TBL] [Abstract][Full Text] [Related]
20. Rg1 protects H9C2 cells from high glucose-/palmitate-induced injury via activation of AKT/GSK-3β/Nrf2 pathway. Yu H; Zhen J; Yang Y; Du J; Leng J; Tong Q J Cell Mol Med; 2020 Jul; 24(14):8194-8205. PubMed ID: 32548942 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]